49. Systemic lupus erythematosus Clinical trials / Disease details

Clinical trials : 946 / Drugs : 722 - (DrugBank : 186) / Drug target genes : 117 - Drug target pathways : 199

53 trials found

diseases per page:

Showing 1 to 10 of 53 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-005776-35-NL (EUCTR)	24/12/2021	13/09/2021	A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lu ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	Serbia;United States;Czechia;Israel;Colombia;United Kingdom;Italy;Hungary;Canada;Argentina;Belgium;R ...
2	NCT05162586 (ClinicalTrials.gov)	December 17, 2021	8/12/2021	A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study t ...	A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study t ...	Systemic Lupus Erythematosus	Drug: M5049 low dose;Drug: M5049 medium dose;Drug: M5049 high dose;Drug: Placebo	EMD Serono Research & Development Institute, Inc.	Merck KGaA, Darmstadt, Germany	Not yet recruiting	18 Years	75 Years	All	440	Phase 2	United States;Germany
3	EUCTR2020-005776-35-HU (EUCTR)	10/11/2021	08/10/2021	A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lu ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	Serbia;United States;Czechia;Israel;Colombia;United Kingdom;Italy;Hungary;Canada;Argentina;Belgium;R ...
4	EUCTR2020-005775-12-GR (EUCTR)	02/11/2021	13/09/2021	A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lu ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	Taiwan;Greece;Spain;Chile;Russian Federation;France;Mexico;Poland;Brazil;Australia;Peru;Bulgaria;Swe ...
5	EUCTR2020-005776-35-IT (EUCTR)	02/11/2021	27/01/2022	A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lu ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: [BIIB059] INN or Proposed INN: HA 1A ANTICORPO MONOCLONALE ...	BIOGEN IDEC RESEARCH LIMITED	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	United States;Czechia;Israel;Colombia;United Kingdom;Italy;Hungary;Canada;Argentina;Belgium;Romania; ...
6	EUCTR2020-003509-72-FR (EUCTR)	21/10/2021	10/03/2021	Efficacy and Safety of Efavaleukin Alfa in Subjects with Active Systemic LupusErythematosus	A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects wi ...	Active Systemic Lupus Erythematosus MedDRA version: 21.1;Level: LLT;Classification code 10025139;Ter ...	Product Name: Efavaleukin Alfa Product Code: AMG 592 INN or Proposed INN: EFAVALEUKIN ALFA Other descri ...	Amgen Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	320	Phase 2	United States;Hong Kong;Taiwan;Greece;Spain;Turkey;Austria;Chile;Russian Federation;Colombia;Switzer ...
7	JPRN-jRCTs021210042	14/10/2021	14/10/2021	Randomized , double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and saf ...	Randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safe ...	Systemic Lupus Erythematosus : SLE Systemic Lupus Erythematosus, SLE;D008180	Group A to which the test drug is administered and Group B to which the placebo is administered will ...	Ishii Tomonori	NULL	Recruiting	>= 20age old	< 80age old	Both	30	N/A	Japan
8	EUCTR2020-005775-12-ES (EUCTR)	05/10/2021	08/07/2021	A Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lu ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy ...	systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Not applicable Product Code: BIIB059 INN or Proposed INN: Not applicable Other descriptiv ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	540	Phase 3	United States;Philippines;Taiwan;Greece;Spain;Chile;Russian Federation;France;Mexico;Poland;Brazil;A ...
9	NCT04956484 (ClinicalTrials.gov)	September 1, 2021	8/7/2021	Belimumab In Treatment of Early Systemic Lupus Erythematosus	A Single-center, Randomized, Open Label, 52-week Study of Belimumab In Treatment of Early Systemic L ...	Lupus Erythematosus, Systemic	Biological: Belimumab;Drug: Standard of care	Peking Union Medical College Hospital	NULL	Not yet recruiting	18 Years	75 Years	All	84	Phase 4	China
10	EUCTR2020-003509-72-BG (EUCTR)	31/08/2021	01/06/2021	Efficacy and Safety of Efavaleukin Alfa in Subjects with Active Systemic LupusErythematosus	A Phase 2b Dose Ranging Study to Evaluate the Efficacy and Safety of Efavaleukin Alfa in Subjects wi ...	Active Systemic Lupus Erythematosus;Therapeutic area: Body processes [G] - Immune system processes [ ...	Product Name: Efavaleukin Alfa Product Code: AMG 592 INN or Proposed INN: EFAVALEUKIN ALFA Other descri ...	Amgen Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	320	Phase 2	United States;Hong Kong;Taiwan;Greece;Spain;Turkey;Austria;Chile;Russian Federation;Colombia;Switzer ...

First Previous1 2 3 4 5 6Next Last